Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

Atlantic Health, Morristown, New Jersey

Texas Oncology- Austin, Austin, Texas

Texas Oncology- Sammons- DFW, Dallas, Texas

The University of Texas M.D. Anderson Cancer Center GI Medical Oncology Dept, Houston, Texas

Texas Oncology- Northeast Texas, Tyler, Texas